American Heart Journal
Volume 141, Issue 2 , Page E7 , February 2001

An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with β-thalassemia major

  • Haralambos I. Karvounis, MD

      Affiliations

    • First Department of Cardiology, Aristotle University Thessaloniki, Greece
    • ,
  • Theodora A. Zaglavara, MD

      Affiliations

    • First Department of Cardiology, Aristotle University Thessaloniki, Greece
    • ,
  • Georgios E. Parharidis, MD

      Affiliations

    • First Department of Cardiology, Aristotle University Thessaloniki, Greece
    • ,
  • Ioannis G. Nouskas, MD

      Affiliations

    • First Department of Cardiology, Aristotle University Thessaloniki, Greece
    • ,
  • Eleni P. Hassapopoulou, MD

      Affiliations

    • Thalessemia Unit, American-Hellenic Educational Progressive Association General Hospital, Thessaloniki, Greece
    • ,
  • Konstantinos D. Gemitzis, MD

      Affiliations

    • First Department of Cardiology, Aristotle University Thessaloniki, Greece
    • ,
  • Georgios E. Louridas, MD, FCCP

      Affiliations

    • First Department of Cardiology, Aristotle University Thessaloniki, Greece

Received 7 August 2000 ,Accepted 6 October 2000.

References 

  1. Olivieri NF, Nathan DG, McMillan J, et al.  Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994;331:574–578
  2. Velchio C, Derchi G. Management of cardiac complications in patients with thalassemia major. Semin Hematol. 1995;32:288–296
  3. Spirito P, Lupi G, Melevendi C, et al.  Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major. Circulation. 1990;82:88–94
  4. Lau KC, Li AM, Hui PW, et al.  Left ventricular function in betathalassemia major. Arch Dis Child. 1989;64:1046–1051
  5. Hou J-W, Wu M-H, Lin K-H, et al.  Prognostic significance of left ventricular diastolic indexes in β-thalassemia major. Arch Pediatr Adolesc Med. 1994;148:862–866
  6. Konstam M, Rousseau M, Kroneberg M, et al.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation. 1992;86:431–438
  7. SOLVD Investigators . Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691
  8. Pitt B. Use of converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction. J Am Coll Cardiol. 1993;22(4 Suppl):158A–161A
  9. Tei C. New noninvasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995;26:135–136
  10. Tei C, Lieng HL, Hodge DO, et al.  New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and in dilated cardiomyopathy. J Cardiol. 1995;26:357–366
  11. Tei C, Dujardin K, Hodgee D, et al.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol. 1996;28:658–664
  12. Appleton CP, Hatle LK, Popp RL. Relation of transmitral velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol. 1988;12:426–440
  13. Kawai K, Takaoka H, Hata K, et al.  Prevalence, predictors, and prognosis of reversal of maladaptive remodelling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;84:671–676
  14. Doherty N, Seelos K, Suzuki J, et al.  Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J Am Coll Cardiol. 1992;19:1294–1302
  15. Mirsky I, Aoyagi T, Ihara T, et al.  Contractile state is the major determinant of functional outcome in patients with left ventricular dysfunction treated with enalapril. Eur Heart J. 1995;16:808–817
  16. Ehlers KH, Levin AR, Markenson AL, et al.  Longitudinal study of cardiac function in thalassemia major. Ann N Y Acad Sci. 1980;344:397–404
  17. Borow K, Propper R, Bierman F, et al.  The left ventricular end-systolic pressure-dimension relation in patients with thalassemia major. Circulation. 1982;66:980–985
  18. Pinamonti B, Zecchin M, DiLenarda A, et al.  Persistence of left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol. 1997;29:604–612
  19. Temporelli P, Corra U, Imparato A, et al.  Reversible restrictive left ventricular filling with optimized oral therapy predicts a more favourable prognosis in patients with chronic heart failure. J Am Coll Cardiol. 1998;31:1591–1597
  20. Stoddard MF, Pearson AC, Kern MJ, et al.  Left ventricular diastolic function: comparison of pulsed Doppler echocardiographic and hemodynamic indexes in subjects with or without coronary artery disease. J Am Coll Cardiol. 1989;13:327–336
  21. Traversi E, Pozzoli M, Cioffi G, et al.  Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with heart failure. Am Heart J. 1996;132:809–819
  22. Choong CY, Abascal VM, Thomas JD, et al.  Combined influence of ventricular loading and relaxation on the transmitral flow velocity profile in dogs measured by Doppler echocardiography. Circulation. 1988;78:672–683
  23. Pahor M, Bernabei R, Sgadari A, et al.  Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension. 1991;18:148–157
  24. Brown L, Duce B, Miric G, et al.  Reversal of myocardial fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. J Am Soc Nephrol. 1999;10(11 Suppl):S143–S148
  25. Jin ZQ, Chen X. Ramipril-induced delayed myocardial protection against free radical injury involves bradykinin B2 receptor-NO pathway and protein synthesis. Br J Pharmacol. 1998;125:556–562
  26. Jay D, Cuella A, Jay E. Superoxide dismutase activity of the captopril-iron complex. Mol Cell Biochem. 1995;146:45–47
  27. Citrin BS, Mensah GA, Byrd BF. Pulmonary vein flow patterns specific for elevated left ventricular filling pressures in older cardiac patients are common in healthy adults <40 years old. Am J Cardiol. 1995;76:730–733
  28. Malkowski M, Guo R, Gray P, et al.  Is the pulmonary venous-transmitral A-wave duration difference altered by age and hypertension?. Am J Cardiol. 1995;76:722–724

☆ Reprint requests: H. I. Karvounis, MD, 101, Egnatia St, 54635 Thessaloniki, Greece. E-mail: jnouskas@hol.gr

PII: S0002-8703(01)66125-8

doi: 10.1067/mhj.2001.112090

American Heart Journal
Volume 141, Issue 2 , Page E7 , February 2001

Article Tools